Comparative Genomics Reveals Distinct Immune-oncologic Pathways in African American Men with Prostate Cancer
Abstract
The role of immune-oncologic mechanisms of racial disparities in prostate cancer remains understudied. Limited research exists to evaluate the molecular underpinnings of immune differences in African American men (AAM) and European American men (EAM) prostate tumor microenvironment (TME).
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jan 01, 2021
- Source ID
- 10.1158/1078-0432.ccr-20-2925
Entities
People
- Adriana Vidal
- Amparo Serna
- Anders E Berglund
- Bruce J Trock
- David J Einstein
- Elai Davicioni
- Eric A Klein
- John L. Cleveland
- Jong Y Park
- Joshua D Campbell
- Julieta Abraham-Miranda
- Kevin H Kensler
- Kosj Yamoah
- Michael R Freeman
- Priti Lal
- R. Jeffrey Karnes
- Raavi Gupta
- Robert B. Den
- Robert J. Rounbehler
- Shivanshu Awasthi
- Stephen J. Freedland
- Steven P Balk
- Sungyong You
- Timothy R Rebbeck
- Yang Liu
Organizations
- Boston University
- Cleveland Clinic
- Harvard University
- Johns Hopkins School of Medicine
- Mayo Clinic
- Prostate Cancer Foundation
- SUNY Downstate College of Medicine
- University of Pennsylvania